课题基金 / 基金详情

MEDI-493 FOR PROPHYLAXIS OF SEVERE RSV DISEASE IN INFANTS

MEDI-493 FOR PROPHYLAXIS OF SEVERE RSV DISEASE IN INFANTS
MEDI-493 用于预防婴儿严重 RSV 疾病
批准号：
6117979
负责人：
MARK H SAWYER
金额：
$1.46万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/6117979
关键词：
antiviral agents bronchopulmonary dysplasia clinical research clinical trials drug administration rate /duration human subject human therapy evaluation infant human (0-1 year) otitis media outcomes research placebos premature infant human respiratory disorder chemotherapy respiratory disorder epidemiology respiratory infections respiratory syncytial virus

项目摘要

项目成果

MARK H SAWYER的其他基金

相似基金

相关文献

中文摘要
翻译
比较MEDI-493与安慰剂在降低 呼吸道合胞病毒（RSV）住院治疗的发生率 早产儿和支气管肺炎婴儿中 发育不良确定每月一次预防性治疗与安慰剂相比的效果 住院结局、疾病严重程度、非RSV住院 呼吸道疾病和中耳炎的发病率。
英文摘要
Compare the safety and efficacy of MEDI-493 to placebo for the reduction of the incidence of respiratory syncytial virus (rsv) hospitalization among infants born prematurely and infants with bronchopulmonary dysplasia. Determine the effect of monthly prophylaxis compared to placebo on hospitalization outcomes, disease severity, hospitalization for non-rsv respiratory disease and incidence of otitis media.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
San Diego-Influenza Coverage Extension (SD-ICE)
Impact of New Adolescent Vaccines
San Diego-Influenza Coverage Extension (SD-ICE)
Impact of New Adolescent Vaccines
海外基金